M. Palladino

New oral anticoagulants

G. Merli, Taki Galanis, L. Thomson, 2011, Journal of Thrombosis and Thrombolysis.

Implementing the new oral anticoagulants into the hospital formulary

G. Merli, L. Thomson, M. Palladino, 2012, American journal of hematology.

Evaluation of the oral direct factor Xa inhibitor – betrixaban

G. Merli, L. Thomson, M. Palladino, 2013, Expert opinion on investigational drugs.

Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis

C. Coleman, T. Bunz, S. Thompson, 2020, Thrombosis Journal.

Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

D. Heinegård, M. Palladino, T. Saxne, 1988, Arthritis and rheumatism.

Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation.

C. Coleman, T. Bunz, S. Thompson, 2020, Journal of the National Medical Association.

Evaluation of the oral direct factor Xa inhibitor – betrixaban

G. Merli, L. Thomson, M. Palladino, 2013, Expert opinion on investigational drugs.

Facilitating Anticoagulation for Safer Transitions: Preliminary Outcomes from an Emergency Department Deep Vein Thrombosis Discharge Program

G. Merli, Taki Galanis, R. Pugliese, 2014, Hospital practice.